Search Results 201-210 of 14643 for MEN2A

1. A Study Evaluating Fecal DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease - Mayo Clinic

   Cells with increased oncogene activity adopt a secretory phenotype. For example, increased levels of c-Src not only inhibit differentiation but also induce ...

2. Cell Free DNA (Cfdna) Blood Assays for the Detection of EGFR and Other Clinically Relevant Gene Mutations in Patients with Non-Small Cell Lung Cancer - Mayo Clinic

   Cell Free DNA (Cfdna) Blood Assays for the Detection of EGFR and Other Clinically Relevant Gene Mutations in Patients with Non-Small Cell Lung Cancer.

3. A Study to Evaluate the Safety and Effectiveness of MOR202 in Anti-PLA2R Antibody-positive Membranous Nephropathy - Mayo Clinic

   The purpose of this study is to assess the safety and tolerability of MOR202 treatment in subjects with Antibody Positive Membranous Nephropathy (aMN).

4. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. A Study of Using Proton Beam Therapy Which Spares Mucosal Tissue Following the Removal of Oropharyngeal Tumors - Mayo Clinic

   The purpose of this study is to evaluate the clinical outcomes of lower intensity (mucosal tissue sparing) proton beam therapy after the surgical removal of ...

6. Execute _Preview Minutes_ on HM00000252

   As a reminder to the lab, eye protection must be worn whenever there is the possibility of a spill or splash. All samples considered biosafety level 2/2+ ...

7. News - Daniel J. Ma, M.D. - Mayo Clinic

   Daniel J. Ma, M.D.. Radiation Oncologist. Request an Appointment · Overview · News ...

8. Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer - Mayo Clinic

   About this study. The primary objective of the study is to compare the objective response rate (ORR) of high dose cemiplimab (HDREGN2810) and standard dose ...

10. Recruitment/Treatment of Minority Patients on Cancer Trials at Mayo Clinic

    About this study. The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment ...